About Kula Bio
Kula Bio is a company based in Natick (United States) founded in 2018 by William Brady. Kula Bio has raised $86.71 million across 6 funding rounds from investors including The Nature Conservancy, Lowercarbon Capital and Grantham Foundation. The company has 12 employees as of December 31, 2021. Kula Bio offers products and services including Xanthobacter and Kula Bio Products. Kula Bio operates in a competitive market with competitors including Ginkgo Bioworks, Pivot Bio, Pluton Biosciences, BioConsortia and NewLeaf Symbiotics, among others.
- Headquarter Natick, United States
- Employees 12 as on 31 Dec, 2021
- Founders William Brady
-
Sectors
Chemicals & MaterialsAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kula Bio, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$86.71 M (USD)
in 6 rounds
-
Latest Funding Round
$15.48 M (USD), Series A
Nov 05, 2025
-
Investors
The Nature Conservancy
& 10 more
-
Employee Count
12
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kula Bio
Kula Bio offers a comprehensive portfolio of products and services, including Xanthobacter and Kula Bio Products.
Supercharged microbe for efficient nitrogen fixation in crops.
Solutions that deliver nitrogen to roots via irrigation systems.
People of Kula Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Kula Bio
Kula Bio has successfully raised a total of $86.71M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $15.48 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kula Bio
Kula Bio has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include The Nature Conservancy, Lowercarbon Capital and Grantham Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on tech startups
|
Locked | Locked | Locked | |
|
Early-stage investments are targeted by iSelect Fund in key sectors.
|
Locked | Locked | Locked | |
|
Early-stage centric tech-focused VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for Kula Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kula Bio
Investment portfolio details for Kula Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kula Bio
Detailed financials for Kula Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kula Bio Comparisons
Peer comparison for Kula Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kula Bio
Kula Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ginkgo Bioworks, Pivot Bio, Pluton Biosciences, BioConsortia and NewLeaf Symbiotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| Locked | Locked | Locked |
Assay-based microbial research services are offered for industrial applications.
|
|
| Locked | Locked | Locked |
Microbial biotech solutions for enhancing crop yields are developed.
|
|
| Locked | Locked | Locked |
Crop inputs are supplied using beneficial plant bacteria for agriculture.
|
Detailed competitors of Kula Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kula Bio
Complete news archive for Kula Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kula Bio
Kula Bio was founded in 2018.
Kula Bio is headquartered in Natick, United States. It is registered at Natick, Massachusetts, United States.
William Brady is the current CEO of Kula Bio. They have also founded this company.
Kula Bio is a funded company, having raised a total of $86.71M across 6 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Kula Bio is 12.
Manufacturer of microbial crop nutrition products. It offers a biological solution that improves the activity of naturally occurring soil microbes to develop fertilizing abilities. Its product claims to facilitate the activity of soil nitrogen-fixing bacteria and enables them to store the energy derived from renewable electricity and carbon dioxide.
Kula Bio's top competitors include Ginkgo Bioworks, Pivot Bio and Fa Bio.
Kula Bio offers Xanthobacter and Kula Bio Products.
Kula Bio has 11 investors. Key investors include The Nature Conservancy, Lowercarbon Capital, Grantham Foundation, iSelect Fund, and Pillar VC.